Education
About Us
Working with TipRanks
Follow Us
Gregory Verdine Insider Profile
4 Followers
Gregory Verdine, Director at Enanta Pharmaceuticals, holds 285.22K shares in Wave Life Sciences (Ticker: WVE), holds 3.32K shares in Enanta Pharmaceuticals (Ticker: ENTA).
Gregory Verdine Enanta Pharmaceuticals (ENTA)Director
Enanta Pharmaceuticals (ENTA)
Director
Ranked #23,862 out of 103,341 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+30.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gregory Verdine holds in companies
Most Profitable Insider Trade
The most profitable trade made by Gregory Verdine
Gregory Verdine's Trading History
Enanta Pharmaceuticals
Mar 28, 2013
Director
Informative Buy
46.54K
$29.42K
Wave Life Sciences
Aug 26, 2025
Director
Uninformative Sell
100.00K
$2.36M
List of latest transactions for each holding click on a transaction to see Gregory Verdine's performance on stock
You May Also Like
Gregory Verdine insider profile FAQ
What is the percentage of profitable transactions made by Gregory Verdine?
The percentage of profitable transactions made by Gregory Verdine is 67%.
What is the average return per transaction made by Gregory Verdine?
The average return per transaction made by Gregory Verdine is 30.50%.
What stocks does Gregory Verdine hold?
Gregory Verdine holds: ENTA, WVE stocks.
What was Gregory Verdine’s latest transaction?
Gregory Verdine latest transaction was an Uninformative Sell of $100.00K.
What was Gregory Verdine's most profitable transaction?
Gregory Verdine’s most profitable transaction was an Informative Sell of WVE stock on November 22, 2019. The return on the trade was 71.60%.
What is Gregory Verdine's role in Enanta Pharmaceuticals?
Gregory Verdine's role in Enanta Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.